All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network
The world-leading experts in MPN shared the top abstracts from ASH 2020 that they believe could have the greatest impact on clinical practice.
ASH 2020 | Practice-changing abstracts in myeloproliferative neoplasms
Did you miss ASH 2020? Download the resource below to view the practice-changing abstracts and the expert opinions from our Steering Committee.Download Here
When can we safely discontinue interferon alpha therapy in patients with MPN?
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the MPN Hub spoke to the Steering Committee Chair, Jean-Jacques Kiladjian, Université de...
ASH 2020: Highlights for polycythemia vera
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the MPN Hub spoke to Tiziano Barbui, Papa Giovanni XXIII Hospital, Bergamo, IT. We asked about highlights for polycythemia...
Subscribe to get the best content related to MPN delivered to your inbox